A federal court froze the 2026 childhood vaccine schedule. Who writes it is the fight.

The Advisory Committee on Immunization Practices spent decades as one of the least visible institutions in American health policy, which was roughly the point. It reviewed vaccine evidence in public, voted, and forwarded recommendations that the CDC almost always adopted. The process was slow and procedural by design.

That process is now the subject of active litigation.

What happened

On June 9, 2025, the Health and Human Services Secretary removed all seventeen sitting ACIP members and subsequently appointed new ones [s1]. The reconstituted committee met in June, September, and December, voting on several vaccine recommendations that CDC and HHS subsequently adopted [s1].

Then, in January 2026, the CDC's Acting Director approved a new childhood immunization schedule developed solely by federal officials — forgoing the usual ACIP process entirely [s1]. The schedule contained six changes reflecting recommendations developed by federal health officials, plus two changes previously recommended by ACIP [s2].

The committee's charter was also revised. It expanded the eligible expertise pool to include pediatric neurodevelopment, toxicology, data and statistical analysis, and health economics — and added "recovery from serious vaccine injuries" as a qualifying expertise area [s1].

The stay

On March 16, 2026, the U.S. District Court for the District of Massachusetts issued a stay in American Academy of Pediatrics v. Kennedy [s1].

The stay's scope is unusually broad. It postpones the effective date of the revised 2026 childhood immunization schedule, the appointments of the thirteen ACIP members appointed by the Secretary beginning in June 2025, and all committee votes taken after June 11, 2025 [s1].

That last clause reaches backward across roughly nine months of committee action.

Why the procedural question is the substantive one

It is tempting to read this as a dispute about particular vaccines. It is more accurately a dispute about who holds the authority to decide, and by what process.

ACIP's recommendations are load-bearing well beyond their advisory label. They flow into insurance coverage requirements, the Vaccines for Children program, state school requirements, and clinical practice. A schedule written outside the committee process does not merely reflect different scientific judgment — it routes around the mechanism through which that judgment was traditionally contested, documented, and made reviewable.

Which is why the litigation targets process rather than any individual recommendation.

What to watch

The stay is not a final ruling. The underlying case continues, and the practical question for clinicians and parents — which schedule is operative — depends on its resolution.

For readers, the immediate answer is that vaccine schedules are set through a legal and administrative process currently in dispute, and that clinical decisions belong with a clinician who knows the individual case. This article is informational and is not medical advice.